| http://www.w3.org/ns/prov#value | - Ceftazidime has been shown to lower mortality in melioidosis,3 but carbapenems, such as imipenem and meropenem, have even lower MICs than ceftazidime and have been shown to be superior in time-kill studies in vitro.17 Given the known morbidity and mortality of infection with the related Bcc in patients with CF, and that multidrug antibiotic therapy is routine for patients with CF with pulmonary ex
|
